Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial-Reference-Cited by-同舟云学术

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial

Published:2016-10-25 Issue:1 Volume:8 Page:
ISSN:1756-994X
Container-title:Genome Medicine
language:en
Short-container-title:Genome Med

Author:

Stockley Tracy L.,Oza Amit M.,Berman Hal K.,Leighl Natasha B.,Knox Jennifer J.,Shepherd Frances A.,Chen Eric X.,Krzyzanowska Monika K.,Dhani Neesha,Joshua Anthony M.,Tsao Ming-Sound,Serra Stefano,Clarke Blaise,Roehrl Michael H.,Zhang Tong,Sukhai Mahadeo A.,Califaretti Nadia,Trinkaus Mateya,Shaw Patricia,van der Kwast Theodorus,Wang Lisa,Virtanen Carl,Kim Raymond H.,Razak Albiruni R. A.,Hansen Aaron R.,Yu Celeste,Pugh Trevor J.,Kamel-Reid Suzanne,Siu Lillian L.,Bedard Philippe L.

Funder

Princess Margaret Cancer Foundation

Cancer Care Ontario

University of Toronto

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13073-016-0364-2.pdf

Reference28 articles.

1. Meric-Bernstam F, Brusco L, Shaw K, Horombe C, Kopetz S, Davies MA, et al. Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials. J Clin Oncol. 2015;33:2753–62.